RT Book, Section
A1 Kim-Katz, Susan
A2 Olson, Kent R.
A2 Anderson, Ilene B.
A2 Benowitz, Neal L.
A2 Blanc, Paul D.
A2 Clark, Richard F.
A2 Kearney, Thomas E.
A2 Kim-Katz, Susan Y.
A2 Wu, Alan H. B.
SR Print(0)
ID 1179990826
T1 BETA2-ADRENERGIC STIMULANTS
T2 Poisoning & Drug Overdose, 7e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071839792
LK accessmedicine.mhmedical.com/content.aspx?aid=1179990826
RD 2024/04/25
AB Beta-adrenergic  agonists  can  be  broadly  categorized  as  having  beta1  and  beta2  receptor  activity.  This  section  describes  the  toxicity  of  beta2-selective  agonists  that  are  commonly  available  for  oral  use:  albuterol  (salbutamol),  metaproterenol,  and  terbutaline  (Table  II–16).  Clenbuterol,  a  potent  beta2  agonist,  is  not  approved  for  human  use  in  the  United  States  but  is  abused  for  its  anabolic  effects.